GLP-1 receptor agonists
-
Two trials involving more than 1,000 adults has all but guaranteed Eli Lilly's experimental drug retatrutide will be up for FDA approval for weight loss and potentially even knee osteoarthritis pain relief. It's a GLP-1-based drug, but not as we know it.
-
Using both the popular weight-loss medication tirzepatide with another hormone mimic may boost the popular drug's effectiveness, according to the results of a recent clinical trial. Essentially, it means greater weight loss than using only Mounjaro.
-
Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials. If successful, genetically enhanced gut bacteria could completely change how we treat type 2 diabetes